CRP - A TARGET FOR THERAPY IN HUMAN DISEASE?
DOI:
https://doi.org/10.7439/ijbar.v3i2.302Abstract
C-reactive protein (CRP) is a widely recognized indicator of inflammation and is known to play an important role in atherogenesis. Recent prospective studies have demonstrated that increased CRP concentrations within the reference interval are a strong predictor of myocardial infarction, stroke, sudden cardiac death, and peripheral vascular disease in apparently healthy adults. The correlation of circulating CRP concentrations with the severity, extent, and progression of many different pathologies, and the prognostic significance of these associations, are consistent with CRP not just being a marker of disease but also contributing to pathogenesis. Knowledge of the structure and function of CRPDownloads
Download data is not yet available.
Downloads
Published
2012-03-01
Issue
Section
Review Article
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
CRP - A TARGET FOR THERAPY IN HUMAN DISEASE?. (2012). International Journal of Biomedical and Advance Research, 3(2), 77-81. https://doi.org/10.7439/ijbar.v3i2.302
